Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight

Fighting misinformation likely will not be successful, the FDA commissioner concedes, but stakeholders should join the campaign to increase the dissemination of truthful information.

Robert Califf at the Milken Institute Future of Health Summit
FDA Commissioner Robert Califf addressed many subjects during a session at the Milken Institute Future of Health Summit. • Source: Derrick Gingery

Robert Califf has resigned himself to the fact that the US Food and Drug Administration’s strategy of waging a full-frontal assault on misinformation has to change.

More from Marketing & Advertising

More from Compliance

How Novo’s Acquisition Of Catalent Cleared European Regulators

 

Now that one of the most controversial pharma M&As of 2024 has closed, the Pink Sheet looks at whether overtures to concerned customers and extended prenotification discussions helped Novo and Catalent seal the deal.

US FDA Blocks 11 Viatris Products, Except Four With Shortage Concerns

 
• By 

Viatris’ oral finished dose manufacturing facility in Indore, India, was slapped with a US Food and Drug Administration import alert and warning letter.

Off-Label Communications: US FDA Clarifies Safe Harbor For Firm-Generated Presentations

 
• By 

Final guidance on communicating scientific information on unapproved uses (SIUU) allows firm-generated presentations to be based on sources other than reprints, but says communications based on nonscientific content are not protected from enforcement.